POAI
$1.18
Predictive Oncology
($.05)
(4.07%)
POAI
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.07)
Revenue:  $0.60 Mil
Thursday
Aug 12
5:20 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when POAI reports earnings?
Beat
Meet
Miss

Where is POAI's stock price going from here?
Up
Flat
Down
Stock chart of POAI
Analysts
Summary of analysts' recommendations for POAI
Score
Grade
Pivots
Resistance
$1.27
$1.24
$1.21

$1.18

Support
$1.15
$1.12
$1.09
Tweet
Growth
Description
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.